ISBI 2021 sponsors

Siemens Healthineers

Our mission is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare.

An estimated five million patients worldwide everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services.

We’re a leading medical technology company with over 120 years of experience and 18,500 patents globally. With over 50,000 employees in more than 70 countries, we’ll continue to innovate and shape the future of healthcare.

UCA Jedi

While supporting the research excellence at the heart of all disciplines, the Université Côte d’Azur actively promotes transdisciplinarity. Only the cross-talk between several disciplines can make it possible to understand the complex world around us. Transdisciplinarity arises through a process of integration and transcending the specific perspectives of each discipline – each bringing its specific approach and analytical tools.

This is why the Université Côte has various tools to support this new scientific approach.

Five academies have been established as part of the UCAJEDI program, each composed of laboratories and teams of excellence, which build new interactions between researchers from different disciplines in the following five areas:

• Academy 1 : Networks, Information and Digital Society
• Academy 2 : Complex Systems
• Academy 3 : Space, Environment, Risk and Resilience
• Academy 4 : Complexity and Diversity of Living Systems
• Academy 5 : Human Societies, Ideas and Environments

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. The cloud-based Median proprietary iBiopsy® research and development platform leverages multimodal Artificial Intelligence technologies and Data Science to meet the promise of precision medicine through cutting edge medical image analysis. iBiopsy® is extracting non-invasive biomarkers from standard medical images to identify the specific signatures of certain diseases. The challenge is to improve patient care and treatment efficacy. iBiopsy® and associated services address multiple clinical indications and target the drug development and the patient care markets.

Labex Primes

In France, LabEx, or Laboratories of Excellence, are the laureates of calls for projects launched under the Investments for the Future Programs (PIA) since 2010, funded by the ANR (National research Agency), which aim at funding research teams around innovative and promising projects. Selected by international juries, these French laboratories provided with significant resources allow their teams to compete on an international level.

The LabEx PRIMES (Physics, Radiobiology, Imaging and Simulation) from “Université de Lyon” has been funded since 2012. Its primary objectives are to develop new concepts and methods in imaging and radiotherapy for the exploration, diagnosis and therapy of cancer and pathologies associated with aging. PRIMES is an interdisciplinary network of 18 research laboratories from the Auvergne Rhone Alps region working in variety of areas ranging from basic physics to instrumentation, experimental and theoretical radiobiology, image acquisition and image processing to simulation and modeling.

In terms of biomedical imaging, PRIMES does not only work on state of the art imaging equipment such as MR/PET, high-field pre-clinical MRI and X-ray spectral CT, for which the University of Lyon has a ground-breaking position, but also contributes to the emergence of new devices in multi-modality imaging at different levels of the conception chain. With the multidisciplinary consortium of PRIMES, we have the ability to address the design of new state-of-the art imaging systems coupled to innovative data processing methods, in signal processing, machine learning and deep learning approaches.

Cambridge Press University

We are proud to launch the new open access journal Biological Imaging which is now open for submissions. Biological Imaging will provide a single forum for important bio imaging research that uses quantitative and computational imaging at its core and enables discoveries and advances in biology from the molecular to tissue scales. Contact us at biologicalImaging@cambridge.org to learn more.